Savient Pharmaceuticals (SVNT) Posts Q4 Loss of 44c/Sh., Misses Views
Tweet Send to a FriendGet Alerts SVNT Hot Sheet
Price: $0.56 -1.75%
EPS Growth %: +30.6%
Financial Fact:
Research and development: 6.13M
Today's EPS Names:
LBIX, ESEA, ISS, More
EPS Growth %: +30.6%
Financial Fact:
Research and development: 6.13M
Today's EPS Names:
LBIX, ESEA, ISS, More
Trade SVNT Now!
Savient Pharmaceuticals (NASDAQ: SVNT) reported Q4 EPS of ($0.44), $0.06 worse than the analyst estimate of ($0.38). Revenue for the quarter came in at $3.71 million versus the consensus estimate of $3.51 million.
For earnings history and earnings-related data on Savient Pharmaceuticals (SVNT) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Savient Pharmaceuticals (SVNT) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Kohls Corp. (KSS) Tops Q1 EPS by 8c; Comps Down 1.9%; Guides Q2
- Autodesk, Inc. (ADSK) Misses Q1 EPS by 3c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
